OncoNano Medicine

OncoNano Medicine is developing a new pH-activated compound that can digitize and harness the changes in pH within diseased tissues, utilizing pH as a biomarker for cancer diagnosis and treatment. pH variability is a proven, simple, and effective identifier of diseased tissue, providing a foundation for the development of a wide range of highly targeted therapeutics and imaging agents. OncoNano Medicine is the first company to advance candidate products using pH as a biomarker for cancer immunotherapy, therapeutic applications, and intraoperative imaging based on pH-sensitive micelle technology.